In the GXN group, Bcl-2 expression in the cortex and hippocampus was remarkably increased (P < 0.05), while Bax expression was remarkably decreased relative to that in the AD group (P < 0.05 and P < 0.01; Figures 9(b) and 9(d)). This evidence concerns the gene BCL2 and Alzheimer disease.